1-7 of 7
Keywords: Circulating tumor cells
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2022) 45 (4): 157–165.
Published Online: 11 January 2022
...Xiuwen Wang; Chao Han; Jizhen Liang; Jiqun Yi; Zhaojun Pan; Yadi Wang Background: Bearing multidimensional tumor-relevant information ranging from genomic alterations to proteomic makeup, circulating tumor cells (CTCs) constitute a promising material for liquid biopsy. The clinical validity of CTCs...
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (3): 93–98.
Published Online: 27 February 2018
... discussion and treatment stratification factors are missing. Patients and Methods: Postmenopausal women with HER2-negative, hormone receptor-positive tumors and persisting circulating tumor cells (CTCs; assessed using the FDA-approved CellSearch® System, Janssen Diagnostics, LLC) after chemotherapy were...
Journal Articles
Oncol Res Treat (2017) 40 (7-8): 430–434.
Published Online: 19 July 2017
... and immunotherapies, including PD-1 antibodies with or without CTLA-4 antibody, that can be used regardless of mutational status. However, long-term tumor control is only achieved in a minority of patients. Liquid biopsy using circulating tumor cells, circulating tumor DNA (ctDNA), circulating mRNA and micro-RNA...
Journal Articles
Oncol Res Treat (2017) 40 (7-8): 417–422.
Published Online: 13 July 2017
... chemoradiation or perioperative chemotherapy followed by esophageal resection. Nearly 50% of the curatively treated patients develop distant metastasis within 5 years, although no metastases were clinically evident at time of treatment. More recently, the concept of circulating tumor cells (CTC) has also been...
Journal Articles
Oncol Res Treat (2016) 39 (3): 112–116.
Published Online: 26 February 2016
... in performing biopsies of metastatic lesions, the phenotype of the primary tumor most often determines the treatment decisions in metastatic breast cancer. Liquid biopsy allows the analysis of several circulating biomarkers like circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) in peripheral blood...
Journal Articles
Subject Area:
Oncology
Oncol Res Treat (2014) 37 (5): 250–254.
Published Online: 04 April 2014
...Fei Fei; Yueyao Du; Genhong Di; Jiong Wu; Zhiming Shao Introduction: Circulating tumor cells (CTCs) represent a biomarker for tumor progression and monitoring therapeutic effects. We evaluated the association between the changes in CTC count and the pathological response to neoadjuvant chemotherapy...